{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:33:05Z","timestamp":1770276785397,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The National Key R&D Program"},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2510005"],"award-info":[{"award-number":["2023YFC2510005"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijrobp.2025.05.063","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:08:34Z","timestamp":1750320514000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nimotuzumab Combined With Chemoradiation Therapy in Newly Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma"],"prefix":"10.1016","volume":"123","author":[{"given":"Yanwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjie","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangfang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoshi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingtang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongrui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-9827","authenticated-orcid":false,"given":"Xiaoguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.05.063_bib0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0002","first-page":"1339","article-title":"Pediatric central nervous system cancers, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gajjar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0003","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/neuonc\/noad220","article-title":"H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions","volume":"26","author":"Van den Bent","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216876","article-title":"Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies","volume":"590","author":"Weisbrod","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0006","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1073\/pnas.84.19.6899","article-title":"Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification","volume":"84","author":"Wong","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0007","first-page":"3620","article-title":"ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma","volume":"9","author":"Gilbertson","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/mabs.1.1.7509","article-title":"Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin","volume":"1","author":"Ramakrishnan","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0009","doi-asserted-by":"crossref","first-page":"re6","DOI":"10.1126\/scisignal.287re6","article-title":"Oncogenic EGFR signaling networks in glioma","volume":"2","author":"Huang","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ijrobp.2003.09.092","article-title":"The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data","volume":"58","author":"Chakravarti","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0011","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.bjc.6604943","article-title":"Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies","volume":"100","author":"Diaz Miqueli","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0012","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/carcin\/bgad038","article-title":"Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma","volume":"44","author":"Chen","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/cam4.614","article-title":"Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo","volume":"5","author":"Nitta","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0014","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00405-022-07609-y","article-title":"A systematic analysis in efficacy and safety of nimotuzumab combined with chemoradiotherapy in treatment of advanced nasopharyngeal carcinoma","volume":"280","author":"Sun","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4161\/cbt.5.4.2522","article-title":"Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I\/II trial","volume":"5","author":"Ramos","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0016","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/neuonc\/nou091","article-title":"Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma","volume":"16","author":"Bartels","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0017","first-page":"305","article-title":"Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood","volume":"118","author":"Massimino","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0018","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","article-title":"Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy \u2013 Results of a United Kingdom phase II trial (CNS 2007 04)","volume":"49","author":"Bailey","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11060-019-03140-z","article-title":"Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): A phase III clinical study","volume":"143","author":"Fleischhack","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0020","series-title":"World Health Organization classification of tumours of the central nervous system","author":"Louis","year":"2021"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0021","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/S1470-2045(20)30166-2","article-title":"Response assessment in diffuse intrinsic pontine glioma: Recommendations from the response assessment in pediatric neuro-oncology (RAPNO) working group","volume":"21","author":"Cooney","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0022","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","article-title":"Role of radiation therapy in the management of diffuse intrinsic pontine glioma: A systematic review","volume":"4","author":"Gallitto","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0023","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/neuonc\/noad031","article-title":"Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908","volume":"25","author":"Dunkel","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0024","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/neuonc\/noab188","article-title":"Phase I\/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children\u2019s Oncology Group Report","volume":"24","author":"Su","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0025","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1038\/s41467-020-16682-y","article-title":"The integrated genomic and epigenomic landscape of brainstem glioma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0026","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.23.01134","article-title":"ONC201 (Dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma","volume":"42","author":"Arrillaga-Romany","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0027","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0028","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: A report from the Children\u2019s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0029","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy","volume":"43","author":"Mandell","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2014.01.013","article-title":"Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A randomized controlled trial","volume":"111","author":"Zaghloul","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0031","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/brainsci13101449","article-title":"The role of reirradiation in childhood progressive diffuse intrinsic pontine glioma (DIPG): An ongoing challenge beyond radiobiology","volume":"13","author":"Lo Greco","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0032","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1158\/2159-8290.CD-23-0131","article-title":"Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways","volume":"13","author":"Venneti","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0033","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1200\/JCO.24.00709","article-title":"Comments and controversies in oncology: The tribulations of trials developing ONC201","volume":"42","author":"Hansford","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0034","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/1078-0432.CCR-22-0803","article-title":"Upfront biology-guided therapy in diffuse intrinsic pontine glioma: Therapeutic, molecular, and biomarker outcomes from PNOC003","volume":"28","author":"Kline","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0035","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0036","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nou104","article-title":"Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria","volume":"17","author":"Jansen","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-017-2514-9","article-title":"External validation of the diffuse intrinsic pontine glioma survival prediction model: A collaborative report from the International DIPG Registry and the SIOPE DIPG Registry","volume":"134","author":"Veldhuijzen van Zanten","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0038","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10143-024-02435-8","article-title":"The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma","volume":"47","author":"Yu","year":"2024","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0039","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma","volume":"139","author":"Pitter","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-023-04549-3","article-title":"Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: A meta-analysis","volume":"166","author":"Arora","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0041","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0042","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-20-1201","article-title":"Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine glioma","volume":"12","author":"Carvalho","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0043","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: A phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0044","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0045","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1158\/1078-0432.CCR-08-3210","article-title":"EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines","volume":"15","author":"Bax","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0046","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-012-0842-3","article-title":"Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas","volume":"108","author":"Li","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0047","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3171\/2021.3.PEDS20738","article-title":"Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: Results of a phase I trial","volume":"28","author":"McCrea","year":"2021","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ijrobp.2025.05.063_bib0048","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-021-03763-1","article-title":"A phase I\/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma","volume":"153","author":"El-Khouly","year":"2021","journal-title":"J Neurooncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:43:47Z","timestamp":1762019027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0360301625005322"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.063","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nimotuzumab Combined With Chemoradiation Therapy in Newly Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}